Malden, MA, United States of America

Sebastian W Gloskowski

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sebastian W Gloskowski

Introduction

Sebastian W Gloskowski is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of genetic research, particularly in the area of retinal and cochlear degeneration. His work focuses on innovative approaches to treat genetic disorders, showcasing his dedication to advancing medical science.

Latest Patents

Sebastian holds a patent for a CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated Usher syndrome. This patent involves compositions for treating subjects with USH2A-associated retinal and/or cochlear degeneration resulting from mutations in exon 13 of the USH2A gene. The method includes the deletion of exon 13 from the USH2A gene or transcripts, as well as the development of genetically modified animals and cells. He has 1 patent to his name.

Career Highlights

Throughout his career, Sebastian has worked with prestigious organizations, including the Massachusetts Eye and Ear Infirmary and Editas Medicine, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research capabilities.

Collaborations

Sebastian has collaborated with notable colleagues such as Eric A Pierce and Carrie M Margulies. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in genetic therapy.

Conclusion

Sebastian W Gloskowski's contributions to genetic research and his innovative patent demonstrate his commitment to improving treatments for genetic disorders. His work continues to inspire advancements in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…